Intended for overactive bladder to manage urinary urgency and support bladder control.
Mechanism of Action
Tolterodine acts as a competitive antagonist at muscarinic receptors. By inhibiting the action of acetylcholine on the detrusor muscle, it reduces involuntary bladder contractions and increases bladder volume.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
6–24 hours
Contraindications
Urinary retention, Gastric retention, Uncontrolled narrow-angle glaucoma, Hypersensitivity to tolterodine
Severe Adverse Events
Angioedema, Tachycardia, Severe confusion — requires immediate medical attention
Information related to Tolterodine is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
